Sabra Healthcare REIT Inc (SBRA)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NASDAQ
Market Cap: $5.35B
Last updated: Nov 17, 2026 at 11:06 AM ET
Sabra Healthcare REIT Inc (SBRA) Financials: Revenue, Profit and Cash Flow
Sabra Healthcare REIT reported revenue of $787.51M for the fiscal year ended Dec 31, 2025, up 11.6% from the year before. That year, net income was $155.51M with a net margin of 19.7%, operating cash flow was $348.61M and free cash flow was $307.09M. The quarter ended Sep 30, 2026 had revenue of $220.15M and net income of $28.56M.
Revenue and Margins
The operating margin was 33.5% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $264.52M, a compound annual rate of 12.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $787.51M | +11.6% | 63.9% | 33.5% | 19.7% |
| Dec 2024 | $705.97M | +8.9% | 67.4% | 36.4% | 17.9% |
| Dec 2023 | $648.57M | +25.2% | 69.7% | 34.2% | 2.1% |
| Dec 2022 | $517.83M | +18.6% | 89.3% | 45.4% | -15.0% |
| Dec 2021 | $436.66M | -25.5% | 98.1% | 48.3% | -25.9% |
| Dec 2020 | $586.45M | -9.4% | 79.6% | 41.1% | 23.6% |
| Dec 2019 | $647.49M | +3.6% | 86.3% | 81.5% | 10.7% |
| Dec 2018 | $624.97M | +95.4% | 91.8% | 49.1% | 44.7% |
| Dec 2017 | $319.82M | +20.9% | 121.3% | 70.2% | 49.5% |
| Dec 2016 | $264.52M | N/A | 96.3% | 60.8% | 26.5% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 22.7% from the year before. In the quarter ended Sep 2026, net income rose 26.8% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $787.51M | $705.97M | $648.57M | $517.83M | $436.66M | $586.45M | $647.49M | $624.97M | $319.82M | $264.52M |
| Cost of revenue | $271.11M | $227.09M | $195.25M | $162.61M | $141.20M | $131.55M | $109.71M | $49.55M | $17.86M | $5.70M |
| Gross profit | $503.53M | $476.15M | $452.27M | $462.20M | $428.34M | $467.02M | $558.48M | $573.86M | $387.79M | $254.82M |
| Operating income | $263.87M | $257.03M | $221.71M | $234.84M | $210.75M | $241.22M | $527.59M | $306.95M | $224.39M | $160.89M |
| Net income | $155.51M | $126.71M | $13.76M | -$77.61M | -$113.26M | $138.42M | $69.02M | $279.12M | $158.38M | $70.20M |
| EBITDA | $351.90M | $306.12M | $290.63M | N/A | N/A | $324.28M | N/A | $360.88M | $228.65M | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $220.15M | $203.40M | $193.29M | $295.51M | $159.21M | $176.31M | $156.48M | $271.43M | $148.53M | $146.91M | $139.10M | $248.45M |
| Gross profit | N/A | N/A | $136.11M | $131.49M | $120.38M | $128.05M | $123.61M | $122.51M | $119.50M | $121.39M | $112.75M | $113.52M |
| Operating income | N/A | N/A | $39.48M | $64.58M | $59.55M | $71.95M | $67.39M | $67.29M | $64.37M | $66.97M | $57.95M | $54.32M |
| Net income | $28.56M | -$25.25M | $40.81M | $27.15M | $22.52M | $65.54M | $40.30M | $46.70M | $29.79M | $23.98M | $26.25M | $17.16M |
Balance Sheet
As of Dec 2025, total debt of $2.53B exceeded cash and equivalents by $2.46B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.49B | $5.30B | $5.39B | $5.75B | $5.97B | $5.99B | $6.07B | $6.67B | $7.03B | $2.27B |
| Current assets | $189.43M | $198.09M | $180.53M | $201.84M | $653.08M | $329.01M | $262.66M | $296.28M | $822.24M | $184.54M |
| Cash and equivalents | $71.54M | $60.47M | $41.28M | $49.31M | $112.00M | $59.08M | $39.10M | $50.23M | $518.63M | $25.66M |
| Total liabilities | $2.67B | $2.56B | $2.58B | $2.69B | $2.59B | $2.58B | $2.58B | $3.41B | $3.60B | $1.25B |
| Short-term debt | $217.58M | $106.55M | $94.43M | $196.98M | $0 | $1.31B | $3.57M | $624.00M | $641.00M | $26.00M |
| Long-term debt | $2.31B | $2.31B | $2.32B | $2.31B | $2.39B | $2.37B | $2.40B | $2.61B | $2.75B | $1.18B |
| Shareholder equity | $2.82B | $2.74B | $2.80B | $3.06B | $3.38B | $3.41B | $3.49B | $3.25B | $3.43B | $1.02B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.43B | $5.51B | $5.59B | $5.49B | $5.56B | $5.33B | $5.23B | $5.30B | $5.37B | $5.35B | $5.37B | $5.39B |
| Total liabilities | $2.59B | $2.76B | $2.80B | $2.67B | $2.74B | $2.62B | $2.53B | $2.56B | $2.62B | $2.59B | $2.61B | $2.58B |
| Cash and equivalents | $36.24M | $231.58M | $116.53M | $71.54M | $200.60M | $95.17M | $22.65M | $60.47M | $63.00M | $36.40M | $59.93M | $41.28M |
| Shareholder equity | $2.84B | $2.75B | $2.79B | $2.82B | $2.82B | $2.71B | $2.70B | $2.74B | $2.74B | $2.76B | $2.77B | $2.80B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 88.1% of operating cash flow. Dividends came to 94.3% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $348.61M | $310.54M | $300.57M | $315.73M | $356.39M | $354.85M | $372.48M | $360.59M | $135.79M | $175.93M |
| Capital expenditures | $41.52M | $54.71M | $84.86M | $54.47M | $42.65M | $47.35M | $25.45M | $27.70M | $6.95M | $1.00M |
| Free cash flow | $307.09M | $255.83M | $215.72M | $261.26M | $313.74M | $307.50M | $347.02M | $332.89M | $128.84M | $174.93M |
| Dividends paid | $289.50M | $280.15M | $277.45M | $277.16M | $262.92M | $278.30M | $335.44M | $325.22M | $182.09M | $119.26M |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | $80.09M | N/A | $499.00K | N/A | N/A |
| Investing cash flow | -$377.96M | -$109.00M | $103.13M | -$216.25M | -$336.20M | -$136.45M | $262.84M | -$258.49M | -$182.56M | $142.36M |
| Financing cash flow | $40.76M | -$181.56M | -$410.30M | -$161.71M | $30.14M | -$202.11M | -$646.18M | -$629.34M | $598.82M | -$300.90M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $128.97M | $85.82M | $98.36M | $87.43M | $99.96M | $80.96M | $80.26M | $79.97M | $97.65M | $80.13M | $52.80M | $78.74M |
| Capital expenditures | $15.90M | $13.31M | $11.85M | $17.34M | $10.61M | $5.79M | $7.78M | $15.52M | $13.83M | $12.43M | $12.94M | $21.06M |
| Free cash flow | $113.07M | $72.51M | $86.51M | $70.09M | $89.35M | $75.17M | $72.48M | $64.44M | $83.82M | $67.70M | $39.86M | $57.68M |
Frequently Asked Questions About SBRA
What is Sabra Healthcare REIT's annual revenue?
Sabra Healthcare REIT reported revenue of $787.51M for the fiscal year ended Dec 31, 2025.
How fast is Sabra Healthcare REIT's revenue growing?
Revenue was up 11.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 15.0%.
Is Sabra Healthcare REIT profitable?
Yes. Sabra Healthcare REIT reported net income of $155.51M for the fiscal year ended Dec 31, 2025, with a net margin of 19.7%.
How much free cash flow does SBRA generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $348.61M minus capital expenditures of $41.52M produced free cash flow of $307.09M.
How much debt does Sabra Healthcare REIT have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.31B, short-term debt of $217.58M and cash and equivalents of $71.54M.
SBRA pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors